ACBD
Price
$2.60
Change
+$0.74 (+39.78%)
Updated
Dec 6 closing price
HYAC
Price
$10.76
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

ACBD vs HYAC

Header iconACBD vs HYAC Comparison
Open Charts ACBD vs HYACBanner chart's image
Annabidiol
Price$2.60
Change+$0.74 (+39.78%)
Volume$100
CapitalizationN/A
Haymaker Acquisition
Price$10.76
Change-$0.00 (-0.00%)
Volume$23.67K
CapitalizationN/A
ACBD vs HYAC Comparison Chart
Loading...
ACBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACBD vs. HYAC commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACBD is a Buy and HYAC is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ACBD: $2.60 vs. HYAC: $10.76)
Brand notoriety: ACBD and HYAC are both not notable
Both companies represent the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: ACBD: 52% vs. HYAC: 77%
Market capitalization -- ACBD: $0 vs. HYAC: $307.89M
ACBD [@Financial Conglomerates] is valued at $0. HYAC’s [@Financial Conglomerates] market capitalization is $307.89M. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $590.24B to $0. The average market capitalization across the [@Financial Conglomerates] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACBD’s FA Score shows that 1 FA rating(s) are green whileHYAC’s FA Score has 0 green FA rating(s).

  • ACBD’s FA Score: 1 green, 4 red.
  • HYAC’s FA Score: 0 green, 5 red.
According to our system of comparison, ACBD is a better buy in the long-term than HYAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACBD’s TA Score shows that 3 TA indicator(s) are bullish while HYAC’s TA Score has 3 bullish TA indicator(s).

  • ACBD’s TA Score: 3 bullish, 4 bearish.
  • HYAC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ACBD and HYAC are a bad buy in the short-term.

Price Growth

ACBD (@Financial Conglomerates) experienced а 0.00% price change this week, while HYAC (@Financial Conglomerates) price change was -0.02% for the same time period.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was -0.78%. For the same industry, the average monthly price growth was +5.02%, and the average quarterly price growth was +29.23%.

Industries' Descriptions

@Financial Conglomerates (-0.78% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACBD YTD gains are higher at: 642.857 vs. HYAC (4.771).
ACBDHYACACBD / HYAC
CapitalizationN/A308M-
EBITDAN/AN/A-
Gain YTD642.8574.77113,474%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A206K-
Total DebtN/A273K-
FUNDAMENTALS RATINGS
ACBD: Fundamental Ratings
ACBD
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACBDHYAC
RSI
ODDS (%)
Bullish Trend 3 days ago
44%
Bearish Trend 3 days ago
12%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
13%
Momentum
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
21%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
27%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
27%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
34%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
8%
Aroon
ODDS (%)
Bearish Trend 3 days ago
39%
Bearish Trend 3 days ago
7%
View a ticker or compare two or three
Ad is loading...
ACBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRNIX30.14N/A
N/A
Virtus NFJ Mid-Cap Value Inst
RLSIX14.65-0.01
-0.07%
RiverPark Long/Short Opportunity Instl
DIFCX12.24-0.02
-0.16%
MFS Diversified Income C
HAITX55.43-0.27
-0.48%
Hartford Core Equity R6
TPLIX13.81-0.11
-0.79%
Timothy Plan Large/Mid Cap Growth I

ACBD and

Correlation & Price change

A.I.dvisor tells us that ACBD and CLRC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACBD and CLRC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACBD
1D Price
Change %
ACBD100%
N/A
CLRC - ACBD
25%
Poorly correlated
N/A
GGAAF - ACBD
24%
Poorly correlated
N/A
HYAC - ACBD
16%
Poorly correlated
N/A
AASP - ACBD
4%
Poorly correlated
+35.14%
ADMG - ACBD
1%
Poorly correlated
N/A
More